Compounds > ephrin-a5

ephrin-a5 and Amyotrophic Lateral Sclerosis

ephrin-a5 has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Boer, A; Lemmens, R; Lenaerts, A; Ludolph, AC; Oeckl, P; Otto, M; Poppe, L; Robberecht, W; Rué, L; Smolders, S; Timmers, M; Van Damme, P; Van Den Bosch, L; van der Vos, J; Weishaupt, JH1

Other Studies

1 other study(ies) available for ephrin-a5 and Amyotrophic Lateral Sclerosis

ArticleYear
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
    Acta neuropathologica communications, 2019, 07-12, Volume: 7, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Ephrin-A5; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Middle Aged; Superoxide Dismutase-1

2019